Medication reconciliation and review for older emergency patients requires improvement in Finland

Int J Risk Saf Med. 2019;30(1):19-31. doi: 10.3233/JRS-180030.

Abstract

Background: 10-30% of hospital stays by older patients are drug-related. The admission phase is important for identifying drug-related problems, but taking an incorrect medication history often leads to medication errors.

Objectives: To enhance medication history recording and identify drug-related problems (DRPs) of older patients admitted to emergency departments (EDs).

Methods: DRPs were identified by pharmacists-led medication reconciliation and review procedures in two EDs in Finland; Helsinki University Hospital (HUS), and Kuopio University Hospital (KUH). One-hundred-and-fifty patients aged ≥65-years, living at home and using ≥6 medicines were studied.

Results: 100% of patients (N = 75) in HUS and 99% in KUH (N = 75), had discrepancies in their admission-medication chart recorded by the nurse or physician. Associations between admission-diagnosis and drug-related problems were found in 12 patients (16%) in HUS and 22 patients (29%) in KUH. Of these, high-alert medications (e.g. antithrombotics, cytostatics, opioids) were linked to eight patients (11%) in HUS and six patients (8%) in KUH. Other acute DRPs were identified in 19 patients (25%) in HUS and 54 patients (72%) in KUH. Furthermore, 67 patients (89%) in HUS and all patients in KUH had non-acute DRPs.

Conclusions: Medication reconciliation and review at admission of older ED patients requires improvement in Finland.

Keywords: Emergency department; clinical pharmacy; drug-related problems; high-alert medications; medication reconciliation; medication review; older patients; polypharmacy.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Emergency Service, Hospital / standards*
  • Female
  • Finland
  • Guidelines as Topic*
  • Humans
  • Male
  • Medication Errors / prevention & control*
  • Medication Reconciliation / standards*
  • Pharmacy Service, Hospital / standards*
  • Polypharmacy*